iShares U.S. Pharmaceuticals ETF IHE
109.09 USD +2.37 (+2.22%)
At closeNov 4, 2026, 6:12 PM EST
108.50 -0.59 -0.54%
After hours · Nov 4, 6:12 PM ET
106.67 Day range 109.09
75.03 52-week range 109.43
- YTD
- +28.60%
- 1 year
- +43.58%
- Market cap
- 1.21B
- EPS (ttm)
- 3.82
- P/E ratio
- 28.57
- YTD return
- +28.60%
- 1-year return
- +43.58%
- Volume
- 342.80K
- Avg volume
- 233.48K
- Open
- 108.89
- Previous close
- 106.72
- Day's range
- 106.67 – 109.09
- 52-week range
- 75.03 – 109.43
YTD +24.22 (+28.54%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 102.42
- 200-day average
- 94.97
About iShares U.S. Pharmaceuticals ETF
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.
News
Alphabet Sinks 11.8%, Small Caps Rally on Strong GDP Growth: Stock Market Today 
Capital Investment Advisors LLC Makes New $630,000 Investment in iShares U.S. Pharmaceuticals ETF $IHE 
Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH? 
From Laggard to Leader: The Surprising Comeback of Healthcare 
Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP? 
Better Pharma ETF: iShares IHE vs. State Street XPH 
Execution of Pharma Tariffs Brings These ETFs Into Focus 
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? 
IHE: Innovation Supports The Outlook, Valuation Limits Conviction 
IHE: Large-Cap Pharma Cools After A Hot Summer
Your note
Sign in to keep a note on IHE — it syncs with the Stock Master app.